Hilton Worldwide Holdings Inc. (HLT) retreated with the stock falling -0.37% or $-0.22 to close at $59.24 on light trading volume of 3.13M compared its three months average trading volume of 4.02M. The McLean Virginia 22102 based company operating under the Lodging industry has been trending up for the last 52 weeks, with the shares price now 49.07% up for the period and up by 6.14% so far this year. With price target of $79.13 and a 58.35% rebound from 52-week low, Hilton Worldwide Holdings Inc. has plenty of upside potential, making it a hold with a view buy.
Hilton Worldwide Holdings Inc., a hospitality company, owns, leases, manages, develops, and franchises hotels, resorts, and timeshare properties worldwide. The company operates through three segments: Ownership, Management and Franchise, and Timeshare. It also licenses its brands to franchisees; provides hotel management services for third parties; and markets and sells timeshare interests owned by Hilton and third parties. In addition, the company provides consumer financing, which includes interest income generated from the origination of consumer loans to finance their purchase of timeshare intervals. It operates hotels under the Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Hilton Hotels & Resorts, Curio – A Collection by Hilton, DoubleTree by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, Tru by Hilton, Homewood Suites by Hilton, Home2 Suites by Hilton, Hilton Grand Vacations, and Hampton Inn brands. As of February 1, 2017, the company had 4,900 properties with approximately 796,000 rooms in 104 countries and territories. Hilton Worldwide Holdings Inc. was founded in 1919 and is headquartered in McLean, Virginia.
Humana Inc. (HUM) gained $3.42 to close the day at a new closing price of $208.74, a 1.67% increase in value from its previous closing price that moved the stock 39.59% above its 52 week low of $150. A total of 3.12M shares exchanged hands during the day compared with its three month average trading volume of 1.64M. The stock, which fluctuated between $204.2 and $209.1 during the day, currently situated -4.02% below its 52 week high. The stock is up by 1.28% in the past one month and up by 5.14% over the past three months. With a one year target estimate of $223 and RSI of 60.08, the stock still has upside potential, making it a hold for now.
Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare, and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only, and health and wellness products to employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2015, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.2 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Lam Research Corporation (LRCX) shares were down in last trading by -1.43% to $114.57. It experienced higher than average volume on day. The stock decreased in value by almost -1.23% over the past week and grew 2.99% in the past month. It is currently trading 3.82% above its 50 day moving average and 20.63% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -3.84% decrease in value from its one year high of $119.14. The RSI indicator value of 52.5, lead us to believe that it is a hold for now.
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing systems used in the fabrication of integrated circuits. It provides thin film deposition products, including SABRE electrochemical deposition products for copper damascene manufacturing; ALTUS systems to deposit conformal atomic layer films for tungsten metallization applications; VECTOR plasma-enhanced chemical vapor deposition (CVD) and atomic layer deposition systems to deposit oxides, nitrides, carbides, multiple patterning films, anti-reflective layers, multi-layer stack films, and diffusion barriers; SPEED high-density plasma CVD products for applications in shallow trench isolation, pre-metal dielectrics, inter-layer dielectrics, inter-metal dielectrics, and passivation layers; and SOLA ultraviolet thermal processing products for the treatment of back-end-of-line low-k dielectric films and front-end-of-line silicon nitride strained films. The company also offers plasma etch products, such as Kiyo products that provide solutions for conductor etch applications; Flex products, which offer technologies and application-focused capabilities for dielectric etch applications; and Syndion products that provide solutions to address various through-silicon via etch applications. In addition, it provides single-wafer clean products, including EOS, Da Vinci, DV-Prime, and SP series products for wet etch and clean applications in wafer-level packaging, including silicon substrate thinning, wafer stress relief, underbump metallization etch, and photoresist removal; and Coronus plasma-based bevel clean products to enhance die yield by removing particles, residues, and unwanted films from the wafer’s edge, as well as legacy products. The company offers its products in the United States, Europe, Taiwan, Korea, Japan, China, and Southeast Asia. Lam Research Corporation was founded in 1980 and is headquartered in Fremont, California.